Colombo Fort Land & Building Balans Gezondheid

Financiële gezondheid criteriumcontroles 1/6

Colombo Fort Land & Building heeft een totaal eigen vermogen van LKR12.4B en een totale schuld van LKR33.4B, wat de schuld-eigenvermogensverhouding op 269.2% brengt. De totale activa en totale passiva bedragen respectievelijk LKR70.8B en LKR58.4B. De EBIT Colombo Fort Land & Building is LKR4.5B waardoor de rentedekking 1.1 is. Het heeft contanten en kortetermijnbeleggingen van LKR3.9B.

Belangrijke informatie

269.2%

Verhouding schuld/eigen vermogen

LK₨33.45b

Schuld

Rente dekkingsratio	1.1x
Contant	LK₨3.90b
Aandelen	LK₨12.43b
Totaal verplichtingen	LK₨58.41b
Totaal activa	LK₨70.84b

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( LKR33.7B ) van CFLB.N0000 } dekken niet de korte termijn passiva ( LKR38.4B ).

Langlopende schulden: De kortetermijnactiva CFLB.N0000 ( LKR33.7B ) overtreffen de langetermijnschulden ( LKR20.1B ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 237.8% ) CFLB.N0000 wordt als hoog beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van CFLB.N0000 is de afgelopen 5 jaar gestegen van 250.9% naar 269.2%.

Schuldendekking: De operationele kasstroom van CFLB.N0000 is negatief, waardoor de schuld niet goed gedekt is.

Rentedekking: De rentebetalingen van CFLB.N0000 op haar schulden worden niet goed gedekt door EBIT ( 1.1 x dekking).

Colombo Fort Land & Building Balans Gezondheid

Financiële gezondheid criteriumcontroles 1/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Recent updates

Second quarter 2025 earnings released: EPS: LK₨0.78 (vs LK₨0.85 loss in 2Q 2024)

The Colombo Fort Land & Building PLC, Annual General Meeting, Sep 30, 2024

First quarter 2025 earnings released: LK₨0.05 loss per share (vs LK₨0.46 profit in 1Q 2024)

Group MD & Executive Director recently bought LK₨89k worth of stock

New minor risk - Share price stability

Group MD & Executive Director recently bought LK₨102k worth of stock

Full year 2024 earnings released: LK₨0.56 loss per share (vs LK₨9.78 profit in FY 2023)

Group MD & Executive Director recently bought LK₨391k worth of stock

Group MD & Executive Director recently bought LK₨310k worth of stock

Group MD & Executive Director recently bought LK₨456k worth of stock

Group MD & Executive Director recently bought LK₨277k worth of stock

Third quarter 2024 earnings released: LK₨0.95 loss per share (vs LK₨2.03 profit in 3Q 2023)

Second quarter 2024 earnings released: LK₨0.85 loss per share (vs LK₨6.87 profit in 2Q 2023)

Group MD & Executive Director recently sold LK₨4.2m worth of stock

New minor risk - Share price stability

Upcoming dividend of LK₨0.25 per share at 0.8% yield

The Colombo Fort Land & Building PLC Proposes First and Final Dividend

The Colombo Fort Land & Building PLC Proposes First and Final Dividend

The Colombo Fort Land & Building PLC, Annual General Meeting, Sep 27, 2023

First quarter 2024 earnings released: EPS: LK₨0.46 (vs LK₨1.55 in 1Q 2023)

Full year 2023 earnings released: EPS: LK₨12.43 (vs LK₨1.48 loss in FY 2022)

Non-Executive Director recently bought LK₨5.7m worth of stock

Third quarter 2023 earnings released: EPS: LK₨2.03 (vs LK₨1.51 in 3Q 2022)

Investor sentiment improves as stock rises 15%

The Colombo Fort Land & Building plc Announces Demise of Ranjeevan Seevaratnam, Independent Non-Executive Director

Second quarter 2023 earnings released: EPS: LK₨6.87 (vs LK₨0.30 in 2Q 2022)

Less than half of directors are independent

Non-Executive Director recently bought LK₨2.1m worth of stock

Non-Executive Director recently bought LK₨3.5m worth of stock

Independent Non Executive Director recently bought LK₨2.6m worth of stock

Independent Non Executive Director recently bought LK₨1.7m worth of stock

First quarter 2023 earnings released: EPS: LK₨1.55 (vs LK₨0.39 in 1Q 2022)

Full year 2022 earnings released: LK₨1.50 loss per share (vs LK₨2.35 loss in FY 2021)

Less than half of directors are independent

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Group MD & Executive Director recently bought LK₨1.4m worth of stock

Group MD & Executive Director recently bought LK₨1.0m worth of stock

Non-Executive Director recently bought LK₨22m worth of stock

Group MD & Executive Director recently bought LK₨206k worth of stock

Second quarter 2022 earnings released: LK₨0.30 loss per share (vs LK₨0.30 loss in 2Q 2021)

First quarter 2022 earnings released: EPS LK₨0.39 (vs LK₨0.51 loss in 1Q 2021)

Group MD & Executive Director recently bought LK₨148k worth of stock

Third quarter 2021 earnings released: EPS LK₨1.11 (vs LK₨1.85 loss in 3Q 2020)

Group MD & Executive Director recently bought LK₨1.2m worth of stock

New 90-day high: LK₨13.40

Second quarter 2021 earnings released: LK₨0.30 loss per share

Group MD & Executive Director recently sold LK₨711k worth of stock

Non-Executive Chairman recently sold LK₨3.8m worth of stock

New 90-day high: LK₨13.30

First quarter earnings released

Full year earnings released - LK₨8.89 loss per share

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven